학술논문
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Document Type
article
Author
Source
Frontiers in Pharmacology, Vol 14 (2023)
Subject
Language
English
ISSN
1663-9812